Is the detection rate of 18F-choline PET/CT influenced by androgen-deprivation therapy?

@article{Chondrogiannis2014IsTD,
  title={Is the detection rate of 18F-choline PET/CT influenced by androgen-deprivation therapy?},
  author={Sotirios Chondrogiannis and Maria Cristina Marzola and Alice Ferretti and Gaia Grassetto and Anna Margherita Maffione and Lucia Rampin and Stefano Fanti and Francesco Giammarile and Domenico Rubello},
  journal={European Journal of Nuclear Medicine and Molecular Imaging},
  year={2014},
  volume={41},
  pages={1293-1300}
}
To evaluate if the detection rate (DR) of 18F-choline (18F-CH) PET/CT is influenced by androgen-deprivation therapy (ADT) in patients with prostate cancer (PC) already treated with radical intent and presenting biochemical relapse. We have retrospectively evaluated 18F-CH PET/CT scans of 325 consecutive PC patients enrolled in the period November 2009 to December 2012 previously treated with radical intent and referred to our centre to perform 18F-CH PET/CT for biochemical relapse. Two… CONTINUE READING